Foghorn Therapeutics Inc.

FHTX

—

Advanced chart & tools →

Foghorn Therapeutics Inc.FHTX

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-1.18

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$30.91M

Net income

$-74.28M

Net margin

-240.3%

Gross margin

—

Dividends & financials

Foghorn Therapeutics Inc. (FHTX) reported revenue of $30.91M and net income of $-74.28M, or $-1.18 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.